<!-- NM_NEWSLETTERTEMPLATE|Closing Bell Newsletter --><!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html xmlns="http://www.w3.org/1999/xhtml" xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office"><head>
    <!-- NM_HTMLTEMPLATE|Responsive Subject Line --><!-- NM_COMPATIBILITY|Subject Line@New The Week Newsletter;Subject Line@New Mens Fitness Newsletter;Subject Line@New Expert Reviews Newsletter;Subject Line@New IT PRO Newsletter;Subject line@Branded Newsletter;Subject line@1 Octane Newsletter;Subject line@1 CarBuyer Newsletter;Subject line@1 Cloud Pro Newsletter;Subject line@1 Womens Fitness Newsletter;Subject line@1 Channel Pro Newsletter;Subject line@1 Den of Geek US Newsletter;Subject line@1 Coach Newsletter;Subject line@Cyclist Newsletter;Subject line@1 Auto Express Newsletter;Subject line@1 KYM Newsletter;Subject line@1 Evo Newsletter;Subject line@Whitepapers Newsletter;Subject line@Alphr Newsletter;Subject line@Kiplinger Newsletter;Subject line@Closing Bell Newsletter --><!-- NM_TITLE|Title field|Subject Line --><!-- NM_TEXTVAR|Subject Line|#||7|1 --><title>What COVID-19 Vaccine Tech May Do for Other Diseases</title><!-- NM_SINGLEFRAME|Subject line|Responsive Subject line -->
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0">
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <!--[if !mso]><!-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <!--<![endif]-->
    <link href="https://fonts.googleapis.com/css?family=Roboto:400,700" rel="stylesheet" type="text/css">      

    <style type="text/css">    
        .ReadMsgBody { width: 100%; background-color: #e7e7e7; }
        .ExternalClass { width: 100%; background-color: #e7e7e7; }
        body { width: 100%; background-color: #e7e7e7; margin: 0; padding: 0; -webkit-font-smoothing: antialiased; font-family: Roboto, Helvetica, sans-serif }
        table { border-collapse: collapse !important; mso-table-lspace: 0pt; mso-table-rspace: 0pt; }
        *[class*="mobileOn"] { display: none !important; max-height: none !important; }
        
        @-ms-viewport{ width: device-width; }
        
        @media only screen and (max-width: 639px){
        .wrapper{ width:100%;  padding: 0 !important; }
        }    
        @media only screen and (max-width: 480px){ 
        .centerClass{ margin:0 auto !important; } 
        .imgClass{width:100% !important; height:auto;}    
        .container{ width:320px;  padding: 0 !important; }
        .header{ width:300px;  padding: 0 !important; }
        .mobile{ width:320px; display:block; padding: 0 !important; }
        .mobile50{ width:320px; padding: 0 !important; text-align:center; }
        .mobile-ad{ width:320px; display:block; padding: 0 !important; text-align:left; }
        .mobile-ad img{ height:90px; }
        *[class="mobileOff"] { width: 0px !important; display: none !important; }
        *[class*="mobileOn"] { display: block !important; max-height: none !important; }
        }    
    </style>
    
    <!--[if gte mso 9]><xml>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
  <o:PixelsPerInch>96</o:PixelsPerInch>
 </o:OfficeDocumentSettings>
</xml><![endif]-->

<!--[if gt mso 15]>
<style type="text/css" media="all">
/* Outlook 2016 Height Fix */
table, tr, td {border-collapse: collapse;}
tr { font-size:0px; line-height:0px; border-collapse: collapse; }
</style>
<![endif]-->

</head>
<body bgcolor="#e7e7e7" marginwidth="0" marginheight="0" leftmargin="0" topmargin="0" yahoo="fix" style="background-color:#e7e7e7; font-family:Roboto,Helvetica,sans-serif;margin:0;padding:0;min-width: 100%; -webkit-text-size-adjust:none;-ms-text-size-adjust:none;">
<div style="display:none;font-size:1px;color:#333333;line-height:1px;max-height:0px;max-width:0px;opacity:0;overflow:hidden;">
<!-- NM_HTMLTEMPLATE|Kiplinger Hidden Preheader --><!-- NM_COMPATIBILITY|Hidden Prehead@Kiplinger Newsletter;Hidden Prehead@Closing Bell Newsletter;Hidden Prehead@Kiplinger Special Report Newsletter --><!-- NM_TITLE|Title field|Hidden Preheader --><!-- NM_TEXTVAR|Hidden Preheader|Plus: Why You Need Umbrella Insurance||0|37 -->Plus: Signs of Cooling in the Housing Market<!-- NM_SINGLEFRAME|Hidden Prehead|Kiplinger Hidden Preheader -->
</div>
    <!-- Start Background -->
    <table width="100%" cellpadding="0" cellspacing="0" border="0">
        <tbody><tr>
            <td width="100%" valign="top" align="center">

            <!-- NM_HTMLTEMPLATE|A Step Ahead Preheader -->
<!-- NM_COMPATIBILITY|Prehead@Closing Bell Newsletter -->
<!-- NM_TITLE|Title field|Preheader date -->

<!-- Start header 1  -->
<table width="600" cellpadding="10" cellspacing="0" border="0" class="wrapper" bgcolor="#e7e7e7">
                <tbody><tr>
        <td align="left" style="color:#666666;font-size:12px;line-height:140%"><!-- NM_TEXTVAR|Preheader message|You are receiving this limited-time email resource as a subscriber to Kiplinger's free e-newsletters. We will continue to publish this throughout the height of the coronavirus outbreak. To unsubscribe at any time, simply click the link in the footer below.||0|262 -->You are receiving this limited-time email resource as a subscriber to Kiplinger's free e-newsletters. To unsubscribe at any time, simply click the link in the footer below.
    </td></tr>
    <tr>
        <td align="center">
                  
            <!-- Start Container  -->
            <table width="580" cellpadding="0" cellspacing="0" border="0" class="header">

<tbody><tr>
                    <td width="300" align="left" style="color: #666666; font-size:12px; line-height:140%;">
                        <!-- NM_TEXTVAR|Preheader date|JANUARY 16, 2020||0|16 -->JUNE 2, 2021
					</td>
                    <td width="280" align="right" style="font-size:12px; line-height:140%;">
                        <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=M803tYfudKAFWFO9qEqe68DWqv1Tm-jLnjM9juozw9AmNmnJUZV5GP1M-Kz6WbXb2CnRoTEPrb7v-V6jeVmf_A~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#666666; text-decoration:underline;">View in browser</a>
                    </td>
                </tr>
            </tbody></table>
            <!-- Start Container  -->                                   
        </td>
    </tr>
                        
</tbody></table> 
<!-- End header 1  --> <!-- NM_SINGLEFRAME|Prehead|Closing Bell Preheader -->
            <!-- NM_HTMLTEMPLATE|A Step Ahead Header -->
<!-- NM_COMPATIBILITY|Header@Closing Bell Newsletter -->
<!-- NM_TITLE|Title field|Strapline -->

<!-- Start header 2  -->
<table width="600" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#FFFFFF">
    <tbody><tr>
        <td align="center">
            <!-- Start Container  -->
            <table width="510" cellpadding="0" cellspacing="0" border="0" bgcolor="#FFFFFF" class="container">
                <tbody><tr>
                    <td height="45" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr>
                <tr>
                    <td width="510" align="middle" style="font-size:14px; line-height:140%;">
                        <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=UGWBAtf9B0ZyYynqBYbsSlsAyVhj9jj1GHqJlnFNBQU3DKvHDmUsVaxIxTNpzfwuXUzB1xteMVKVYwu3nV_3eQ~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~"><!-- NM_URLVAR|A Step Ahead Logo|https://mediacloud.kiplinger.com/image/private/s--BGJ62oDc--/v1599247614/email/a_step_ahead_logo2.png||22|100 --><img width="400" src="https://mediacloud.kiplinger.com/image/private/s--BGJ62oDc--/v1599247614/email/a_step_ahead_logo2.png"></a>
                    </td>
                </tr>
                <tr>
                    <td width="510" align="middle" style="color:#999999; font-family:Roboto, Helvetica, sans-serif; font-size:14px; line-height:200%;">
                        <!-- NM_TEXTVAR|Strapline|DAILY INSIGHTS FOR INVESTORS||0|28 -->HOW TO PROTECT AND GROW<br>YOUR BUSINESS AND INVESTMENTS NOW
                    </td>
                </tr>
                <tr>
                    <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr>
            </tbody></table>
            <!-- Start Container  -->                   
        </td>
    </tr>                       
</tbody></table> 
<!-- End header 2 -->
<!-- NM_SINGLEFRAME|Header|Closing Bell Header --> 
            <!-- NM_FEEDTEMPLATE|Closing Bell Feed -->
<!-- NM_COMPATIBILITY|Frame 1@Closing BellNewsletter -->

<!-- NM_HTMLTEMPLATE|A Step Ahead Content -->
<!-- NM_COMPATIBILITY|Frame 1@Closing Bell Feed -->

<!-- Kiplinger 1: START -->
<table width="600" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#FFFFFF">
    <tbody><tr>
        <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
    </tr>
    <tr>
        <td align="center">                  
            <!-- Start Container  -->
            <table width="510" cellpadding="0" cellspacing="0" border="0" class="container" bgcolor="#FFFFFF">
                <tbody><tr>
                    <td height="15" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr>                 
                <tr>
					<!-- teaser -->
                    <td style="color:#666666;font-size:20px;line-height: 150%;">
						<p style="margin-bottom: 1em;margin-top: 0;"><!-- NM_HTMLFEEDITEMDESCRIPTION|Description|Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.|1|0|213 --><strong>The messenger RNA technology at the heart of Pfizer&#8217;s (<a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=Kv2TVaeFPaK4Ox3BlmotzI_pqzJYwKCdUxHrbs7ZLQebjVEeUS-xeJh74my03XjfHxrbN-8jMfDcipcV1l0WsA~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~">PFE</a>) and Moderna&#8217;s (<a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=MZUwvyKmDbp6wlmzdkXFhbb9BTTAHEwR1SgNY00qytf2WpzJqcpDoMbMU1HZuzWRN3h0YinG5LPp3ftR5O2-ig~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~">MRNA</a>) successful COVID-19 vaccines has many other potential uses as well, and could revolutionize disease treatment.</strong> (mRNA carries a message to cells to do something, such as produce antibodies. Once delivered, it dissolves.) Researchers will be starting Phase 1 trials next year for <strong>a universal flu vaccine, </strong>and also for<strong> HIV and herpes vaccines.</strong> The tech could also create<strong> a universal coronavirus vaccine, </strong>including for<strong> the common cold.</strong> Pfizer and GlaxoSmithKline (<a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=-Y1vS0UERRXTzmnCnRtzjUWSTQMoGJ7wB-dyYksmwfUNpcIdnXVJIfkbMSt5uE6jVg0VqU0Tn8UrZlGpWvdAPQ~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~">GSK</a>) are working on a vaccine against<strong> respiratory syncytial virus</strong>, or RSV, which can be deadly for infants and young children.</p><p></p>
						
<!-- Kiplinger See Also START -->
<!-- NM_FEEDITEMTEMPLATE|A Step Ahead See Also -->
<!-- NM_COMPATIBILITY|See Also Frame@A Step Ahead Content -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- A Step Ahead See Also START -->
                        <table width="510" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#FFFFFF">
    <tbody><tr>
        <td height="10" style="font-size:10px; line-height:100%;"><hr></td><!-- Spacer -->
    </tr>
    <tr>
        <td align="center">                  
            <!-- Start Container  -->
            <table width="510" cellpadding="0" cellspacing="0" border="0" class="container"><tbody><tr>
        <td height="10" style="font-size:10px; line-height:100%;"></td><!-- Spacer -->
    </tr>
                <tr>
                    <td width="100%" class="mobile" align="center" style="line-height: 140%; color:#666666;font-size: 14px;letter-spacing: 1.5px;">
                       <!-- NM_TEXTCONTENT|Strap|SPONSORED CONTENT FROM SMARTASSET|1|0|33 -->SPONSORED CONTENT FROM VANGUARD PERSONAL ADVISOR
                    </td>
                </tr>                
                <tr>
                    <td height="10" style="font-size:10px; line-height:120%;"> </td><!-- Spacer -->
               </tr>
                <tr>
                    <td><!-- NM_URLVAR|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=MJR_IkT59ETpocUDwFfojHw1T8HBngBnbGUi62KzMq6FOHrEhKFjhei-x-OQKyOoSv_Sg3CEedaV9bZ4j8rcRA~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#000000; font-family: Roboto, Helvetica, sans-serif; font-size:20px; font-weight:700; text-decoration:none; line-height:1.2;"><!-- NM_TEXTCONTENT|Headline|Headline|1|0|8 -->Build a Custom Financial Plan with Vanguard</a></td>
                </tr> 
                <tr>
                    <td height="5" style="font-size:10px; line-height:150%;"> </td><!-- Spacer -->
                </tr> 
               <tr>
                    <td style="color:#666666;font-size:20px;line-height: 140%;">
                    <p style="margin-bottom: 1em;margin-top: 0;"><!-- NM_HTMLCONTENT|Description|Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.|1|0|213 -->At Vanguard, we're invested in you. Which is precisely why we've created Vanguard Personal Advisor Services®, providing remote access to expert financial advisors, real-time goal tracking, and more confidence you'll meet your goals. There's never been a more perfect time to get started.</p>
                    </td>
                </tr>
                <tr>
                    <td style="color:#CC2936;font-size:16px;line-height: 140%;"><!-- NM_URLVAR|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=enVHZC2LHIbY1eCW6USYlOA-7BmcwBeYQIVcX98RgNUdbR8xlSkQufOEY1N1wcI6m2c-7iPotPWBaMH8N3piAw~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#CC2936;text-decoration:none;font-weight: 700;">READ MORE</a><p></p></td>
                </tr>                
            </tbody></table>
            <!-- End Container  -->          
        </td>
    </tr>
    <tr>
        <td height="10" style="font-size:10px; line-height:150%;"></td><!-- Spacer -->
    </tr>  
    <tr>
        <td height="10" style="font-size:10px; line-height:150%;"><hr></td><!-- Spacer -->
    </tr>                     
</tbody></table> 
<!-- End A Step Ahead See Also  --><!-- NM_SINGLEFRAME|See Also Frame|Kiplinger See Also|1 -->
<!-- End Kiplinger See Also  -->

<!-- NM_HTMLTEMPLATE|Kiplinger Afterword -->
<!-- NM_COMPATIBILITY|Afterword Frame@Closing Bell Story with Image -->

<p style="margin-bottom: 1em;margin-top: 1em;">
<!-- NM_HTMLCONTENT|Afterword|Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.|1|0|213 --></p><p><strong>Cancer is another target.</strong> Moderna and BioNTech (<a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=tQl_3nSG_FMBHmR65JQUx1RymbLXlROh4L1wxLOmzYQvtNxWGX9P0XSpVI4hIi0v5KSqpJE0b8Efb5osuCQGkw~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~">BNTX</a>) are working on that. Also,<strong> autoimmune diseases such as lupus, MS, and arthritis.</strong> BioNTech has found the treatment to be effective in mice. mRNA tech could be helpful in gene therapy by replacing a defective gene with a new one. That would help combat <strong>sickle cell anemia</strong>. Translate Bio (<a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=Ejh5I-uxDU84SGhBNBmLbiRqEwSEKLfj_p_UFsvnAoHpXfLzCB7yVAL0UGrUQdl36ekWRqSTpxE6H0EpMWQGxw~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~">TBIO</a>) has started early stage trials in people for its application of mRNA tech to <strong>cystic fibrosis</strong>. Finally, there are potential applications for <strong>malaria and tickborne diseases</strong>, which would be huge breakthroughs for large parts of the world.</p>
<p><strong>If you own a home or want to buy one, you probably already know just how frothy the housing market is.</strong> Home prices rose 19% in April from a year earlier, a pace that is putting houses out of reach for many would-be buyers. <strong>But there are some faint signs that the market is starting to cool off</strong>, according to last week&#8217;s issue of <em>The Kiplinger Letter</em>. Home sales declined in April for the third consecutive month, because there simply haven&#8217;t been enough houses for sale to meet demand. However, <strong>the inventory of homes for sale is starting to creep higher</strong>, finally. <strong>And more consumers are rethinking their desire to buy</strong>; a survey conducted by Fannie Mae showed that, for the first time since the survey started asking the question, more people say that now is a bad time to buy a home than a good time. <strong>If these trends of more houses hitting the market and fewer people looking to buy continue, that should eventually slow the pace of price increases. </strong>And in the long run, a market with a better match between supply and demand will probably be a healthier market.</p>
<p></p>
<!-- NM_SINGLEFRAME|Afterword Frame|Kiplinger Afterword|1 -->
<p><em>Free download, <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=gttapg9Ubud0SuIlURBNwh_684OWbKu5Nz3FKoL3qonamrgBPFeyKNkYpzYtpOt0u9dDPtP0gpvDAqtMnCfe6w~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" target="_blank">The Kiplinger Letter's Forecast</a>. No information required from you.</em></p>

                    </td>
                </tr>

           </tbody></table>
            <!-- End Container  -->          
        </td>
    </tr>
    <tr>
        <td height="45" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
    </tr>                        
</tbody></table> 
<!-- End Kiplinger 1  --> 

<!-- NM_MULTIFRAME|Frame 1|Closing Bell Story with Image|1 --><!-- NM_HTMLTEMPLATE|Closing Bell Native Ad -->
<!-- NM_COMPATIBILITY|Frame 1@Closing Bell Newsletter;Frame 1@Closing Bell Feed -->
<!-- NM_TITLE|Title field|Strap -->

<!-- Widget (start) -->
<!-- Start Ad -->
<table width="600" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#FFFFFF">
    <tbody><tr>
        <td height="14" valign="middle" style="display:block; font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
    </tr>
    <tr>
        <td align="center">                  
            <!-- Start Container  -->
            <table width="510" cellpadding="0" cellspacing="0" border="0" class="container" bgcolor="#FFFFFF">
                <tbody><tr>
                    <td class="mobile" align="middle" style="line-height: 140%; color:#666666;font-size: 14px;letter-spacing: 1.5px;">
                       <!-- NM_TEXTCONTENT|Strap|SPONSORED CONTENT FROM SMARTASSET|1|0|33 -->SPONSORED CONTENT FROM SMARTASSET
                    </td>
                </tr>                
                <tr>
                    <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr>                 
                <tr>
                    <td>                        
                       <!-- NM_URLVAR|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=YtJzxMXy9SJemO0DDbbBmslsnGwtfDHR_sD6DqTNTjOba8HNnIt0E8aFaw9fOE7bHvMwlveFuuprjFO1VYNGEA~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~"><!-- NM_URLVAR|Image|https://www.kiplinger.com/kipimages/happy_beard_man_solid_background_002.jpg|1|10|76 --><img src="https://mediacloud.kiplinger.com/image/private/s--rD2Vw-P9--/v1614912161/email%20ads/smartasset/600x400_smartasset_linda.jpg" width="510" class="imgClass" style="width:100%; display:block; line-height:130%;"></a>
                    </td>
                </tr>
                <tr>
                    <td height="21" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
               <tr>
                    <td><!-- NM_URLVAR|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=mGwF_ce5jj9BSHVhK6z2C-qXVQnqQD2Zbr0_CiSnTN0DhZw-roD-bmLggq3xuNn_fyupEHCYew22sle9ADrO-A~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#000000;text-decoration:none;font-size:30px;font-weight:700; line-height: 120%;"><!-- NM_TEXTCONTENT|Headline|Headline|1|0|8 -->Find the Right Financial Advisor for You</a></td>
                </tr>
                <tr>
                    <td height="15" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
                <tr>
                    <td style="color:#666666;font-size:20px;line-height: 140%;">
                    <p style="margin-bottom: 1em;margin-top: 0;"><!-- NM_HTMLCONTENT|Description|Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.|1|0|213 -->Ready to kick your retirement plan into high gear? Compare fiduciary financial advisors in your area.</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <table align="center" bgcolor="#FFFFFF">
                            <tbody><tr>
                                <td align="center" bgcolor="#CC2936" valign="middle"><!-- NM_URLVAR|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=hrYWGOCyp0R0f5fmJ3u68IUz0XQ_AhxN5m9j3XvSg0KiaJKAnVzRu2MsRl6y9xHlEQyJMI0HU2WZQwznGFGfuQ~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="font-size:16px; font-family: Roboto, Helvetica, sans-serif; font-weight:700; color:#ffffff; text-decoration:none; line-height:300%; border-left:50px solid #CC2936; border-right:50px solid #CC2936; border-top:15px solid #CC2936; border-bottom:15px solid #CC2936;">READ MORE</a></td>
                            </tr>
                        </tbody></table>
                    </td>
                </tr>                  
            </tbody></table>
            <!-- End Container  -->          
        </td>
    </tr>
    <tr>
        <td height="15" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
    </tr>                        
</tbody></table> 
<!-- End Ad  -->
<!-- Widget (end) -->

<!-- NM_FEEDTEMPLATE|Kiplinger List Feed -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger Newsletter;Frame 1@Closing Bell Newsletter -->
<!-- NM_TITLE|Title field|List Title -->

<!-- latest investing news -->
<table width="600" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#FFFFFF">
    <tbody><tr>
        <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
    </tr>
    <tr>
        <td align="center">                  
            <!-- Start Container  -->
            <table width="510" cellpadding="0" cellspacing="0" border="0" class="container" bgcolor="#FFFFFF">
                <tbody><tr>
                    <td class="mobile" align="middle" style="line-height: 150%; color:#666666;font-size: 14px;letter-spacing: 1.5px;"><!-- NM_TEXTCONTENT|List Title|LATEST INVESTING NEWS FROM KIPLINGER.COM|1|0|40 -->LATEST INVESTING NEWS FROM KIPLINGER.COM</td>
                </tr>                
                <tr>
                    <td height="21" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr>

<!-- NM_FEEDITEMTEMPLATE|Kiplinger List Story -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger List Feed -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- Kiplinger More : START -->
               <tr>
                    <td><!-- NM_FEEDITEMLINK|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=9wjR1YpgB1BBWyPiVn1TwCqgk437uUz5h5Y1BJXCAe7MTpIRc0bVRK4xzdLgMolWWES9ijYX5Kj0LacjnSsEfQ~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#000000;text-decoration:none;font-size:20px; font-weight:700; line-height:125%;"><!-- NM_FEEDITEMTITLE|Headline|Headline|1|0|8 -->Hurricane Season: Home, Family and Financial Planning Tips</a>
                    </td>
                </tr>
                <tr>
                     <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
<!-- Kiplinger More : END -->

<!-- NM_FEEDITEMTEMPLATE|Kiplinger List Story -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger List Feed -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- Kiplinger More : START -->
               <tr>
                    <td><!-- NM_FEEDITEMLINK|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=uiOV7ew3IU-fCIUmo5H6cl-e3BMIZQ9ndgazA4AhRv4kKx7ouiRoac44Dx_-KeS2fyVkl0lsYIAPiGM1dexczQ~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#000000;text-decoration:none;font-size:20px; font-weight:700; line-height:125%;"><!-- NM_FEEDITEMTITLE|Headline|Headline|1|0|8 -->IRS Extends Tax Deadlines for West Virginia Storm Victims</a>
                    </td>
                </tr>
                <tr>
                     <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
<!-- Kiplinger More : END -->

<!-- NM_FEEDITEMTEMPLATE|Kiplinger List Story -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger List Feed -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- Kiplinger More : START -->
               <tr>
                    <td><!-- NM_FEEDITEMLINK|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=P0oJdVc70s8UgyqAj23Z3N0GSdz7lTI1TXsgvuhCBgD6sqxdEJf9tziMb7mhx8DdcTWFy4UZgh2frIrl40OrTA~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#000000;text-decoration:none;font-size:20px; font-weight:700; line-height:125%;"><!-- NM_FEEDITEMTITLE|Headline|Headline|1|0|8 -->Housing: Supply Constraints Are Slowing Construction</a>
                    </td>
                </tr>
                <tr>
                     <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
<!-- Kiplinger More : END -->

<!-- NM_FEEDITEMTEMPLATE|Kiplinger List Story -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger List Feed -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- Kiplinger More : START -->
               <tr>
                    <td><!-- NM_FEEDITEMLINK|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=sGeCE9f5OaakrWi0StmfUySHJMuUDbWBirU6NK3TaSXDOg9AmyVux4KgapS1-XFhVlDF7P1GrwYRTdxsf9yxhg~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#000000;text-decoration:none;font-size:20px; font-weight:700; line-height:125%;"><!-- NM_FEEDITEMTITLE|Headline|Headline|1|0|8 -->30 Top Stock Picks That Billionaires Love</a>
                    </td>
                </tr>
                <tr>
                     <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
<!-- Kiplinger More : END -->

<!-- NM_FEEDITEMTEMPLATE|Kiplinger List Story -->
<!-- NM_COMPATIBILITY|Frame 1@Kiplinger List Feed -->
<!-- NM_TITLE|Title field|Headline|0|0|0 -->

<!-- Kiplinger More : START -->
               <tr>
                    <td><!-- NM_FEEDITEMLINK|Link|#|1|9|1 --><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=kk11ndesynjRGqzdxdBztSBMzDPIUiqU6euKcP3Z-VRsF-IT3iHHr-QegagA07NFilemg8Ci8wkEDN8jlO4-lQ~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#000000;text-decoration:none;font-size:20px; font-weight:700; line-height:125%;"><!-- NM_FEEDITEMTITLE|Headline|Headline|1|0|8 -->Sign Up Free for Kiplinger's Retirement E-Newsletter to Plan for and Make the Most of a Richly Rewarding Retirement</a>
                    </td>
                </tr>
                <tr>
                     <td height="11" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
                </tr> 
<!-- Kiplinger More : END -->

<!-- NM_MULTIFRAME|Frame 1|Kiplinger List Story|5 -->


            </tbody></table>
            <!-- End Container  -->          
        </td>
    </tr>
    <tr>
		<td height="45" style="font-size:1px; line-height:100%;">&nbsp;</td><!-- Spacer -->
	</tr>                        
</tbody></table> 
<!-- End latest investing news  --><!-- NM_MULTIFRAME|Frame 1|Closing Bell Feed|1 -->
	    <!-- NM_HTMLTEMPLATE|A Step Ahead Footer (Coronavirus) -->
<!-- NM_COMPATIBILITY|Footer@Closing Bell Newsletter -->

<!-- Footer -->
<table width="600" cellpadding="0" cellspacing="0" border="0" class="wrapper" bgcolor="#e7e7e7">
    <tbody><tr style="border-collapse: collapse;">
        <td bgcolor="#e7e7e7" height="30" style="font-size:10px; line-height:130%; border-collapse:collapse;"> </td><!-- Spacer -->
    </tr>                     
    <tr style="border-collapse: collapse;">
        <td align="center">                  
            <!-- Start Container  -->
            <table border="0" cellpadding="0" cellspacing="0" width="95%" bgcolor="#e7e7e7" class="container" style="border-collapse: collapse;">
				<tbody>
                    <tr>
                        <td bgcolor="#e7e7e7" align="center" style="border-collapse:collapse; color:#fff; font-size:20px; font-family: Roboto, Helvetica, Arial, sans-serif;"><img src="https://mediacloud.kiplinger.com/image/private/s--Y2F2iy-y--/v1590676042/email/cb_kiplinger_999999.png" width="200" height="63" style="display:block;" alt="Kiplinger" title="Kiplinger"></td>
                    </tr>
                    <tr>
                        <td bgcolor="#e7e7e7" height="20" style="border-collapse:collapse; font-size:10px; line-height:120%;"> </td><!-- Spacer -->
                    </tr> 
                    <tr>
                        <td bgcolor="#e7e7e7" align="center" style="border-collapse:collapse;">
                        <table border="0" cellpadding="0" cellspacing="0" width="70%" bgcolor="#e7e7e7" class="container" style="border-collapse: collapse;">
							<tbody>
                                <tr>
                                    <td width="30%"></td>
                                    <td align="center" width="10%" style="border-collapse:collapse; color:#fff;"><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=aR1dXLPI7PrtADiFuK7cQjKAJjPDj_53gyxb7kPMsVCC4yVDGgGUsHZ3n2uxP12yw6TFkOVs-EuCou5OCzJ66Q~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#cc2936; text-decoration:none;">
                                    <img src="https://mediacloud.kiplinger.com/image/private/s--VgMkLGEV--/v1590676042/email/cb_fb_100.png" width="25" height="26" alt="Facebook" title="Facebook" style="border-collapse:collapse; color:#fff;display:block;"></a></td>
                                    <td width="4%"></td>
                                    <td align="center" width="10%" style="border-collapse:collapse; color:#fff;"><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=uR7ZjzOQ-HYUoKUed9ScMMhDeuazYFm1Z8niEUlpIw6kQvTXpGJrBGZMMBadWWR6iTuJjAjyt7E3M9EHxlcDVA~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#cc2936; text-decoration:none;">
                                    <img src="https://mediacloud.kiplinger.com/image/private/s--3BiG3O86--/v1590676041/email/cb_tw_100.png" width="25" height="26" alt="Twitter" title="Twitter" style="border-collapse:collapse; color:#fff;display:block;"></a></td>
                                    <td width="6%"></td>
                                    <td align="center" width="10%" style="color:#fff;"><a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=BD53_aq8-mM8PkK2DT6eaBVK0sUykPCvX3fH3OUmpioDUTwHl4aF04KaWsXS4hu0ZeCkA9HlGDWVTIae17CtDA~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="border-collapse:collapse; color:#cc2936; text-decoration:none;">
                                    <img src="https://mediacloud.kiplinger.com/image/private/s--ii3iyun6--/v1590676041/email/cb_li_100.png" width="25" height="26" alt="LinkedIn" title="LinkedIn" style="border-collapse:collapse; color:#fff;display:block;"></a></td>                                    
                                    <td width="30%"></td>
                                </tr>
                            </tbody>
                        </table>
                        </td>
                    </tr>

                    <tr>
                        <td bgcolor="#e7e7e7" height="20" style="border-collapse:collapse; font-size:10px; line-height:120%;"> </td><!-- Spacer -->
                    </tr> 
                    <tr>
                        <td bgcolor="#e7e7e7" align="center" style="border-collapse:collapse; color:#666666; font-size:15px; font-family: Roboto, Arial, Helvetica, sans-serif; line-height:120%;">Send this to a friend. <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=_aRRZ0v1DV-Hr_0Tytzaecxj-aRT2ch3EsSO8yoFgVSxTmbja62sjRMfWAgk14STR3cSHP7mCNOm7Sq64Nehaw~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#666666; text-decoration:underline">Click here.</a></td>
                    </tr>
                    <tr>
                        <td bgcolor="#e7e7e7" height="20" style="border-collapse:collapse; font-size:10px; line-height:120%;"> </td><!-- Spacer --> 
                    </tr> 
                    <tr>
                        <td bgcolor="#e7e7e7" style="border-collapse:collapse; color:#666666; font-size:12px; line-height:120%; font-family: Roboto, Helvetica, Arial, sans-serif;" align="center">
                        All content ©2021 The Kiplinger Washington Editors<br>
                        1100 13th Street, NW, Suite 1000<br>
                        Washington, D.C. 20005<br><br>
Thank you for subscribing to Kiplinger's A Step Ahead, a free resource to help readers navigate the economic recovery from COVID-19. If you ever wish to stop receiving this service, please <a href="https://alertskiplinger.mmsend.com/link.cfm?r=ZZynG1mOGJkbHvdqE5guDg~~&amp;pe=KzMGx56n9DVDcygdWEIjNhgaJ-u8LAG6UvHidvsFWTRApU06jSi_xf8svG18LtWrYN4Z0VJRRby67xqvC8usYQ~~&amp;t=KG0ks_Xj8Tz0F1Bmf8dhXg~~" style="color:#666666; text-decoration:underline"> </a>.
                        </td>
                    </tr> 
                    <tr>
                        <td bgcolor="#e7e7e7" height="30" style="border-collapse:collapse; font-size:10px; line-height:120%;"> </td><!-- Spacer --> 
                    </tr> 
                                                   
                </tbody>
            </table>     
            <!-- End Container  -->          
        </td>
    </tr>                     
</tbody></table> 
<!-- End footer  --> 

<!-- NM_SINGLEFRAME|Footer|Closing Bell Footer -->

            </td>
        </tr>
    </tbody></table>
    <!-- End Background -->
    

<table cellpadding="0" cellspacing="0" width="100%" style="border-collapse: collapse"><tbody><tr><td><img height="1" style="display: block" width="1" border="0" src="https://alertskiplinger.mmsend.com/spacer.cfm?tracking_id=51141290284&amp;jid=51893077"></td></tr></tbody></table></body></html>
